Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

NCT00003397 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: rituximab
BIOLOGICAL: sargramostim
DRUG: carmustine
DRUG: cisplatin
DRUG: cyclophosphamide
DRUG: dexamethasone
DRUG: etoposide
DRUG: gemcitabine hydrochloride
DRUG: melphalan
DRUG: paclitaxel
PROCEDURE: bone marrow ablation with stem cell support
PROCEDURE: peripheral blood stem cell transplantation

Sponsor

University of Maryland, Baltimore

Collaborators

[object Object]